Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Long-Term Deferred Tax (2017 - 2025)

Aethlon Medical filings provide 11 years of Long-Term Deferred Tax readings, the most recent being $34.4 million for Q1 2025.

  • On a quarterly basis, Long-Term Deferred Tax rose 3.42% to $34.4 million in Q1 2025 year-over-year; TTM through Mar 2025 was $34.4 million, a 3.42% increase, with the full-year FY2025 number at $34.4 million, up 3.42% from a year prior.
  • Long-Term Deferred Tax hit $34.4 million in Q1 2025 for Aethlon Medical, up from $33.3 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $34.4 million in Q1 2025 to a low of $24.8 million in Q1 2021.
  • Median Long-Term Deferred Tax over the past 5 years was $30.0 million (2023), compared with a mean of $29.9 million.
  • Biggest five-year swings in Long-Term Deferred Tax: increased 10.82% in 2023 and later increased 3.42% in 2025.
  • Aethlon Medical's Long-Term Deferred Tax stood at $24.8 million in 2021, then increased by 9.4% to $27.1 million in 2022, then grew by 10.82% to $30.0 million in 2023, then grew by 10.78% to $33.3 million in 2024, then increased by 3.42% to $34.4 million in 2025.
  • The last three reported values for Long-Term Deferred Tax were $34.4 million (Q1 2025), $33.3 million (Q1 2024), and $30.0 million (Q1 2023) per Business Quant data.